ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
福泰製藥
446.83
+5.09
1.15%
盤後:
445.50
-1.3300
-0.30%
19:53 EDT
成交量:
153.02萬
成交額:
6.86億
市值:
1,133.69億
市盈率:
26.52
高:
453.16
開:
445.61
低:
443.86
收:
441.74
52周最高:
507.92
52周最低:
362.50
股本:
2.54億
流通股本:
2.54億
量比:
1.08
換手率:
0.60%
股息:
- -
股息率:
- -
每股收益(TTM):
16.85
每股收益(LYR):
15.32
淨資產收益率:
24.20%
總資產收益率:
12.14%
市淨率:
5.86
市盈率(LYR):
29.17
資料載入中...
總覽
公司
新聞資訊
公告
大冢製藥稱,腎病藥物在晚期臨床試驗中可維持腎功能
路透中文
·
06/05
異動解讀|福泰製藥盤中上漲3.07%,FDA受理Povetacicept生物製品許可申請
行情直击
·
06/04
福泰製藥(VRTX)股票6月2日收盤下跌3.03%:真相來了
TradingKey中文
·
06/03
異動解讀|福泰製藥盤中下跌3.06%,FDA受理Povetacicept生物製品許可申請
行情直击
·
06/03
異動解讀|福泰製藥盤中下跌3.09%,FDA受理Povetacicept生物製品許可申請
行情直击
·
06/01
福泰製藥宣佈美國FDA受理其生物製品許可申請 尋求Povetacicept在IgA腎病中的加速批准
美股速递
·
06/01
福泰製藥宣佈舒澤曲吉新藥上市申請獲加拿大衞生部受理,用於治療成人中重度急性疼痛
美股速递
·
05/22
美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股
路透中文
·
05/20
美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股
路透中文
·
05/20
福泰製藥與德國達成協議 確保12歲及以上符合條件的患者獲得Casgevy治療
美股速递
·
05/06
福泰製藥在德國達成Casgevy®基因療法報銷協議 覆蓋鐮狀細胞病與輸血依賴型β地中海貧血治療
美股速递
·
05/06
美國研究綜述-應用材料公司、Axsome Therapeutics、安森美半導體
路透中文
·
05/05
Vertex公司盈利超出預期,新型囊性纖維化藥物銷量激增
路透中文
·
05/05
財報前瞻|福泰製藥本季度營收預計小幅增長,機構觀點偏多
财报Agent
·
04/27
BUZZ-Vertex簽署全球藥物輸送技術協議,Halozyme股價上漲
路透中文
·
04/07
美國FDA批准福泰製藥Alyftrek和Trikafta標籤擴展
金吾财讯
·
04/02
福泰製藥宣佈美國FDA批准Alyftrek®與Trikafta®標籤擴展,覆蓋全美約95%囊性纖維化患者
美股速递
·
04/01
福泰製藥完成向FDA提交Povetacicept治療成人IgAN的生物製劑許可申請
美股速递
·
04/01
BUZZ-董事會聘用多發性硬化症藥物資深專家後,Immunic 股價上漲
路透中文
·
03/31
BUZZ-Vertex 因腎病藥物數據獲得券商評級上調而上漲
路透中文
·
03/18
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/VRTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRTX\",,,,,undefined,":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰製藥","latestPrice":446.83,"timestamp":1780689600000,"preClose":441.74,"halted":0,"volume":1530180,"hourTrading":{"tag":"盘后","latestPrice":445.5,"preClose":446.83,"latestTime":"19:53 EDT","volume":55160,"amount":24644211.149,"timestamp":1780703617420,"change":-1.33,"changeRate":-0.002977,"amplitude":0.012026},"delay":0,"changeRate":0.01152261511296232,"floatShares":253718831,"shares":253718831,"eps":16.85,"marketStatus":"未開盤","change":5.09,"latestTime":"06-05 16:00:00 EDT","open":445.605,"high":453.16,"low":443.86,"amount":686374939.494,"amplitude":0.021053,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":16.85,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":441.74,"preHourTrading":{"tag":"盘前","latestPrice":445.481,"preClose":441.74,"latestTime":"09:28 EDT","volume":281,"amount":124596.36664,"timestamp":1780666080058,"change":3.741,"changeRate":0.008469,"amplitude":0.017824},"postHourTrading":{"tag":"盘后","latestPrice":445.5,"preClose":446.83,"latestTime":"19:53 EDT","volume":55160,"amount":24644211.149,"timestamp":1780703617420,"change":-1.33,"changeRate":-0.002977,"amplitude":0.012026},"volumeRatio":1.0802446910931331,"impliedVol":0.2756,"impliedVolPercentile":0.2311},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRTX\",,,,,undefined,":{"symbol":"VRTX","floatShares":253718831,"roa":"12.14%","roe":"24.20%","lyrEps":15.32,"volumeRatio":1.0802446910931331,"shares":253718831,"dividePrice":0,"high":453.16,"amplitude":0.021053,"preClose":441.74,"low":443.86,"week52Low":362.5,"pbRate":"5.86","psRate":"9.28","week52High":507.92,"institutionHeld":0.8924,"latestPrice":446.83,"eps":16.85,"divideRate":0,"volume":1530180,"delay":0,"ttmEps":16.85,"open":445.605,"prevYearClose":453.36,"prevWeekClose":447.54,"prevMonthClose":447.54,"prevQuarterClose":446.54,"fiveDayClose":447.54,"twentyDayClose":425,"sixtyDayClose":492.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-04","symbol":"VRTX","fiscalQuarterEnding":"2026/03","expectedEps":3.69,"name":null,"time":"盤後","type":"earning","dateTimestamp":1777867200000,"reportTimeType":"post","actualEps":3.95},{"market":"US","date":"2026-02-12","symbol":"VRTX","fiscalQuarterEnding":"2025/12","expectedEps":4.4,"name":null,"time":"盤後","type":"earning","dateTimestamp":1770872400000,"reportTimeType":"post","actualEps":3.54},{"market":"US","date":"2025-11-03","symbol":"VRTX","fiscalQuarterEnding":"2025/09","expectedEps":4,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"post","actualEps":4.22},{"market":"US","date":"2025-08-04","symbol":"VRTX","fiscalQuarterEnding":"2025/06","expectedEps":3.74,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"post","actualEps":4},{"market":"US","date":"2025-05-05","symbol":"VRTX","fiscalQuarterEnding":"2025/03","expectedEps":3.69,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"post","actualEps":3.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3235,"buy":0.5,"hold":0.1471,"sell":0,"strongSell":0.0294,"meanLabel":"BUY","meanPercent":0.5,"analysts":34,"updateTime":1779336000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRTX","date":"2026-06-05","current":26.518101,"percent":0.492671,"low":-277.356576,"twenty":-112.392461,"median":25.928232,"eighty":29.128891,"high":33.424389,"avg":-21.667597,"sd":98.998812,"marketCap":112116004905},"quantilePoints":[{"date":"2021-06-11","current":18.090297,"twenty":-33.034034,"median":21.664582,"eighty":66.441226,"marketCap":49966251816},{"date":"2021-06-18","current":17.605753,"twenty":-33.034034,"median":21.664582,"eighty":66.441226,"marketCap":48627916297},{"date":"2021-06-25","current":18.214011,"twenty":-33.034034,"median":21.664582,"eighty":66.441226,"marketCap":50307954502},{"date":"2021-07-02","current":18.79509,"twenty":-33.034034,"median":21.664582,"eighty":66.441226,"marketCap":51912921662},{"date":"2021-07-09","current":18.572031,"twenty":-33.034034,"median":21.664582,"eighty":66.441226,"marketCap":51296821365},{"date":"2021-07-16","current":18.958167,"twenty":-33.034034,"median":21.664582,"eighty":66.441226,"marketCap":52363347929},{"date":"2021-07-23","current":18.791341,"twenty":-33.034034,"median":21.664582,"eighty":66.441226,"marketCap":51902567035},{"date":"2021-07-30","current":26.255738,"twenty":-32.878679,"median":21.684877,"eighty":66.441226,"marketCap":52295575662},{"date":"2021-08-06","current":26.137211,"twenty":-32.699507,"median":21.79201,"eighty":66.441226,"marketCap":52059495823},{"date":"2021-08-13","current":25.315335,"twenty":-32.555816,"median":21.904258,"eighty":66.441226,"marketCap":50422502657},{"date":"2021-08-20","current":25.509407,"twenty":-32.335922,"median":21.926167,"eighty":66.441226,"marketCap":50809050964},{"date":"2021-08-27","current":26.039524,"twenty":-32.240297,"median":22.010565,"eighty":66.441226,"marketCap":51864924528},{"date":"2021-09-03","current":25.795957,"twenty":-32.144294,"median":22.090449,"eighty":66.441226,"marketCap":51379793431},{"date":"2021-09-10","current":24.561189,"twenty":-31.564706,"median":22.132426,"eighty":66.441226,"marketCap":48920412256},{"date":"2021-09-17","current":24.526022,"twenty":-31.250463,"median":22.172927,"eighty":66.441226,"marketCap":48850366590},{"date":"2021-09-24","current":23.915151,"twenty":-31.250463,"median":22.240936,"eighty":66.441226,"marketCap":47633647422},{"date":"2021-10-01","current":23.490537,"twenty":-31.250463,"median":22.284828,"eighty":66.441226,"marketCap":46787910857},{"date":"2021-10-08","current":23.306885,"twenty":-31.250463,"median":22.427476,"eighty":66.441226,"marketCap":46422116822},{"date":"2021-10-15","current":23.675491,"twenty":-31.250463,"median":22.50828,"eighty":66.441226,"marketCap":47156299177},{"date":"2021-10-22","current":23.903428,"twenty":-31.250463,"median":22.570124,"eighty":66.441226,"marketCap":47610298866},{"date":"2021-10-29","current":24.08708,"twenty":-31.250463,"median":22.655469,"eighty":66.441226,"marketCap":47976092902},{"date":"2021-11-05","current":22.530796,"twenty":-31.250463,"median":22.667741,"eighty":66.441226,"marketCap":49032486243},{"date":"2021-11-12","current":21.881217,"twenty":-30.963776,"median":22.667741,"eighty":66.441226,"marketCap":47618845468},{"date":"2021-11-19","current":21.365994,"twenty":-30.618396,"median":22.667741,"eighty":66.441226,"marketCap":46497594421},{"date":"2021-11-26","current":21.448944,"twenty":-29.58,"median":22.667741,"eighty":66.441226,"marketCap":46678113297},{"date":"2021-12-03","current":23.81126,"twenty":-29.014149,"median":22.689685,"eighty":66.441226,"marketCap":51819087483},{"date":"2021-12-10","current":24.30779,"twenty":-28.932131,"median":22.782268,"eighty":66.441226,"marketCap":52899658220},{"date":"2021-12-17","current":25.064853,"twenty":-28.455823,"median":22.875525,"eighty":66.441226,"marketCap":54547210778},{"date":"2021-12-23","current":26.105814,"twenty":-28.108186,"median":22.901751,"eighty":66.441226,"marketCap":56812595546},{"date":"2021-12-31","current":25.656016,"twenty":17.5737,"median":22.959054,"eighty":66.441226,"marketCap":55833725584},{"date":"2022-01-07","current":25.918885,"twenty":17.691789,"median":23.021234,"eighty":66.278504,"marketCap":56405792445},{"date":"2022-01-14","current":27.345388,"twenty":18.248501,"median":23.084657,"eighty":66.278504,"marketCap":59510208608},{"date":"2022-01-21","current":26.64674,"twenty":18.438383,"median":23.190095,"eighty":66.278504,"marketCap":57989782019},{"date":"2022-01-28","current":26.407322,"twenty":18.584777,"median":23.436518,"eighty":66.278504,"marketCap":61848590000},{"date":"2022-02-04","current":26.29214,"twenty":18.733983,"median":23.496944,"eighty":66.278504,"marketCap":61578820000},{"date":"2022-02-11","current":25.422886,"twenty":18.940734,"median":23.62274,"eighty":66.278504,"marketCap":59542942257},{"date":"2022-02-18","current":24.957668,"twenty":19.335082,"median":23.698937,"eighty":66.278504,"marketCap":58453354020},{"date":"2022-02-25","current":25.032668,"twenty":19.440794,"median":23.887566,"eighty":66.278504,"marketCap":58629011937},{"date":"2022-03-04","current":25.941366,"twenty":19.597787,"median":23.933705,"eighty":66.278504,"marketCap":60757273074},{"date":"2022-03-11","current":25.704409,"twenty":19.674548,"median":24.044098,"eighty":66.278504,"marketCap":60202295887},{"date":"2022-03-18","current":27.073977,"twenty":19.753169,"median":24.141091,"eighty":66.278504,"marketCap":63409962194},{"date":"2022-03-25","current":27.603326,"twenty":19.795239,"median":24.191932,"eighty":66.278504,"marketCap":64649750679},{"date":"2022-04-01","current":28.929416,"twenty":19.839497,"median":24.35855,"eighty":66.278504,"marketCap":67755586309},{"date":"2022-04-08","current":30.46529,"twenty":19.930307,"median":24.512346,"eighty":66.278504,"marketCap":71352754953},{"date":"2022-04-14","current":31.301161,"twenty":19.962743,"median":24.592655,"eighty":66.278504,"marketCap":73310449707},{"date":"2022-04-22","current":29.393548,"twenty":20.004928,"median":24.83879,"eighty":66.278504,"marketCap":68842628780},{"date":"2022-04-29","current":29.697897,"twenty":20.03888,"median":24.979951,"eighty":66.278504,"marketCap":69555443515},{"date":"2022-05-06","current":26.495904,"twenty":20.069136,"median":25.049425,"eighty":66.278504,"marketCap":64944111176},{"date":"2022-05-13","current":25.743589,"twenty":20.095798,"median":25.075059,"eighty":66.278504,"marketCap":63100110697},{"date":"2022-05-20","current":26.982144,"twenty":20.136569,"median":25.176256,"eighty":66.278504,"marketCap":66135933954},{"date":"2022-05-27","current":28.561902,"twenty":20.150944,"median":25.37233,"eighty":66.278504,"marketCap":70008079204},{"date":"2022-06-03","current":28.11427,"twenty":20.188906,"median":25.439029,"eighty":66.278504,"marketCap":68910886131},{"date":"2022-06-10","current":26.595031,"twenty":20.234793,"median":25.610387,"eighty":66.278504,"marketCap":65187079339},{"date":"2022-06-17","current":27.451689,"twenty":20.281872,"median":25.666723,"eighty":66.278504,"marketCap":67286835779},{"date":"2022-06-24","current":30.525644,"twenty":20.326294,"median":25.794079,"eighty":66.441226,"marketCap":74821406390},{"date":"2022-07-01","current":29.979928,"twenty":20.361307,"median":25.84565,"eighty":66.441226,"marketCap":73483802714},{"date":"2022-07-08","current":30.707202,"twenty":20.376137,"median":25.918885,"eighty":66.441226,"marketCap":75266421762},{"date":"2022-07-15","current":30.555904,"twenty":20.406092,"median":25.946801,"eighty":66.441226,"marketCap":74895575619},{"date":"2022-07-22","current":29.246395,"twenty":20.422199,"median":25.989839,"eighty":66.441226,"marketCap":71685838308},{"date":"2022-07-29","current":29.258916,"twenty":20.438509,"median":26.026369,"eighty":66.441226,"marketCap":71716529024},{"date":"2022-08-05","current":23.122777,"twenty":20.475653,"median":26.067809,"eighty":66.441226,"marketCap":73868024600},{"date":"2022-08-12","current":23.643788,"twenty":20.498425,"median":26.067809,"eighty":66.441226,"marketCap":75532446638},{"date":"2022-08-19","current":24.00665,"twenty":20.525428,"median":26.067809,"eighty":66.441226,"marketCap":76691643497},{"date":"2022-08-26","current":22.613005,"twenty":20.545845,"median":26.067809,"eighty":66.441226,"marketCap":72239506889},{"date":"2022-09-02","current":22.561627,"twenty":20.58503,"median":26.067809,"eighty":66.441226,"marketCap":72075372821},{"date":"2022-09-09","current":23.450316,"twenty":20.600547,"median":26.067809,"eighty":66.441226,"marketCap":74914379287},{"date":"2022-09-16","current":23.257646,"twenty":20.6197,"median":26.067809,"eighty":66.441226,"marketCap":74298876530},{"date":"2022-09-23","current":22.755099,"twenty":20.647469,"median":26.067809,"eighty":66.441226,"marketCap":72693440172},{"date":"2022-09-30","current":23.243999,"twenty":20.689956,"median":26.067809,"eighty":66.441226,"marketCap":74255278418},{"date":"2022-10-07","current":23.700787,"twenty":20.721578,"median":26.067809,"eighty":66.441226,"marketCap":75714532870},{"date":"2022-10-14","current":23.538623,"twenty":20.772143,"median":26.067809,"eighty":66.441226,"marketCap":75196484717},{"date":"2022-10-21","current":24.083718,"twenty":20.804968,"median":26.067809,"eighty":66.441226,"marketCap":76937844600},{"date":"2022-10-28","current":24.615935,"twenty":20.829646,"median":26.067809,"eighty":66.441226,"marketCap":80572879868},{"date":"2022-11-04","current":24.218335,"twenty":20.899332,"median":26.067809,"eighty":66.441226,"marketCap":79271454206},{"date":"2022-11-11","current":23.782308,"twenty":20.929742,"median":26.067809,"eighty":66.441226,"marketCap":77844249733},{"date":"2022-11-18","current":24.673968,"twenty":20.968734,"median":26.067809,"eighty":66.441226,"marketCap":80762831542},{"date":"2022-11-25","current":24.544571,"twenty":21.009704,"median":26.067809,"eighty":66.441226,"marketCap":80339290646},{"date":"2022-12-02","current":25.202533,"twenty":21.053627,"median":26.067809,"eighty":66.441226,"marketCap":82492931929},{"date":"2022-12-09","current":24.48497,"twenty":21.101183,"median":26.067809,"eighty":66.441226,"marketCap":80144205143},{"date":"2022-12-16","current":23.903078,"twenty":21.181197,"median":26.067809,"eighty":66.441226,"marketCap":78239554569},{"date":"2022-12-23","current":22.718119,"twenty":21.224091,"median":26.067809,"eighty":66.441226,"marketCap":74360946729},{"date":"2022-12-30","current":22.646755,"twenty":21.288692,"median":26.067809,"eighty":66.441226,"marketCap":74127357508},{"date":"2023-01-06","current":22.758898,"twenty":21.288692,"median":26.014776,"eighty":65.424607,"marketCap":74494426284},{"date":"2023-01-13","current":23.600368,"twenty":21.288692,"median":25.988984,"eighty":64.595198,"marketCap":77248725564},{"date":"2023-01-20","current":24.298326,"twenty":21.288692,"median":25.946801,"eighty":63.820293,"marketCap":79533279487},{"date":"2023-01-27","current":25.208807,"twenty":21.288692,"median":25.918885,"eighty":63.175723,"marketCap":82513467245},{"date":"2023-02-03","current":23.606642,"twenty":21.288692,"median":25.841544,"eighty":59.763724,"marketCap":77269260881},{"date":"2023-02-10","current":23.015953,"twenty":21.288692,"median":25.785684,"eighty":58.629059,"marketCap":76458994553},{"date":"2023-02-17","current":22.726512,"twenty":21.288692,"median":25.640278,"eighty":56.257185,"marketCap":75497472564},{"date":"2023-02-24","current":22.239725,"twenty":21.288692,"median":25.602235,"eighty":54.586924,"marketCap":73880367400},{"date":"2023-03-03","current":22.482732,"twenty":21.288692,"median":25.431258,"eighty":54.101829,"marketCap":74687634524},{"date":"2023-03-10","current":22.229665,"twenty":21.288692,"median":25.368738,"eighty":53.331888,"marketCap":73846945512},{"date":"2023-03-17","current":22.889806,"twenty":21.288692,"median":25.208807,"eighty":52.673648,"marketCap":76039935504},{"date":"2023-03-24","current":24.330818,"twenty":21.288692,"median":25.166496,"eighty":52.094166,"marketCap":80826978135},{"date":"2023-03-31","current":24.383444,"twenty":21.28871,"median":25.11231,"eighty":51.133283,"marketCap":81001800315},{"date":"2023-04-06","current":24.915117,"twenty":21.28871,"median":25.061975,"eighty":50.76355,"marketCap":82768018515},{"date":"2023-04-14","current":25.848109,"twenty":21.288692,"median":25.033996,"eighty":50.643774,"marketCap":85867417489},{"date":"2023-04-21","current":25.522439,"twenty":21.288674,"median":25.033332,"eighty":50.320478,"marketCap":84785542122},{"date":"2023-04-28","current":26.314902,"twenty":21.288674,"median":25.033332,"eighty":49.973017,"marketCap":87418105515},{"date":"2023-05-05","current":27.384363,"twenty":21.288656,"median":25.032668,"eighty":49.792738,"marketCap":89264809044},{"date":"2023-05-12","current":27.685395,"twenty":21.288656,"median":25.032668,"eighty":49.325365,"marketCap":90246080640},{"date":"2023-05-19","current":26.821016,"twenty":21.288656,"median":25.032668,"eighty":49.072256,"marketCap":87428466136},{"date":"2023-05-26","current":26.281372,"twenty":21.288656,"median":25.032668,"eighty":48.842312,"marketCap":85669388708},{"date":"2023-06-02","current":25.569485,"twenty":21.288656,"median":25.032668,"eighty":48.767836,"marketCap":83348848792},{"date":"2023-06-09","current":26.277422,"twenty":21.288656,"median":25.032668,"eighty":48.326754,"marketCap":85656511128},{"date":"2023-06-16","current":27.5811,"twenty":21.288656,"median":25.032668,"eighty":47.793832,"marketCap":89906112528},{"date":"2023-06-23","current":27.50841,"twenty":21.288638,"median":25.02995,"eighty":47.535059,"marketCap":89669165056},{"date":"2023-06-30","current":27.509991,"twenty":21.279509,"median":25.027233,"eighty":46.998635,"marketCap":89674316088},{"date":"2023-07-07","current":27.318784,"twenty":21.279509,"median":25.027233,"eighty":46.635872,"marketCap":89051041216},{"date":"2023-07-14","current":27.57636,"twenty":21.279509,"median":25.027233,"eighty":46.295825,"marketCap":89890659432},{"date":"2023-07-21","current":28.587698,"twenty":21.279509,"median":25.027233,"eighty":45.49919,"marketCap":93187319912},{"date":"2023-07-28","current":27.625346,"twenty":21.279509,"median":25.027233,"eighty":44.63174,"marketCap":90050341424},{"date":"2023-08-04","current":26.67238,"twenty":21.279509,"median":25.027233,"eighty":36.841737,"marketCap":89749890968},{"date":"2023-08-11","current":26.644767,"twenty":21.279509,"median":25.027233,"eighty":34.522351,"marketCap":89656976834},{"date":"2023-08-18","current":26.375543,"twenty":21.279509,"median":25.027233,"eighty":34.245707,"marketCap":88751064034},{"date":"2023-08-25","current":26.597979,"twenty":21.279509,"median":25.027233,"eighty":34.069206,"marketCap":89499538997},{"date":"2023-09-01","current":26.718401,"twenty":21.279509,"median":25.027233,"eighty":33.965058,"marketCap":89904747857},{"date":"2023-09-08","current":26.382446,"twenty":21.279509,"median":25.027233,"eighty":33.850395,"marketCap":88774292567},{"date":"2023-09-15","current":26.800856,"twenty":21.279509,"median":25.027233,"eighty":33.645353,"marketCap":90182199783},{"date":"2023-09-22","current":27.174011,"twenty":21.279509,"median":25.027233,"eighty":33.492135,"marketCap":91437831058},{"date":"2023-09-29","current":27.037482,"twenty":21.279509,"median":25.027233,"eighty":33.411271,"marketCap":90978422287},{"date":"2023-10-06","current":27.239975,"twenty":21.279509,"median":25.027233,"eighty":33.067031,"marketCap":91659792599},{"date":"2023-10-13","current":28.226364,"twenty":21.279509,"median":25.027233,"eighty":32.690996,"marketCap":94978891920},{"date":"2023-10-20","current":27.980917,"twenty":21.279509,"median":25.027233,"eighty":31.698674,"marketCap":94152988512},{"date":"2023-10-27","current":27.710926,"twenty":21.25212,"median":25.012559,"eighty":30.708456,"marketCap":93244494763},{"date":"2023-11-03","current":28.882167,"twenty":21.25212,"median":25.012559,"eighty":30.559065,"marketCap":97185602588},{"date":"2023-11-10","current":27.372479,"twenty":21.25212,"median":25.012559,"eighty":30.356608,"marketCap":94974291126},{"date":"2023-11-17","current":25.47348,"twenty":21.25212,"median":25.012559,"eighty":30.055388,"marketCap":88385332112},{"date":"2023-11-24","current":26.219117,"twenty":21.25212,"median":25.012559,"eighty":29.927965,"marketCap":90972471279},{"date":"2023-12-01","current":26.350569,"twenty":21.25212,"median":25.012559,"eighty":29.679853,"marketCap":91428570515},{"date":"2023-12-08","current":26.2867,"twenty":21.26125,"median":25.022885,"eighty":29.536588,"marketCap":91206962976},{"date":"2023-12-15","current":30.196842,"twenty":21.26125,"median":25.022885,"eighty":29.373548,"marketCap":104773982614},{"date":"2023-12-22","current":29.75347,"twenty":21.25212,"median":25.012559,"eighty":29.335178,"marketCap":103235614005},{"date":"2023-12-29","current":30.395134,"twenty":21.242991,"median":25.002233,"eighty":29.301697,"marketCap":105461996715},{"date":"2024-01-05","current":30.906089,"twenty":21.240471,"median":24.991736,"eighty":29.267472,"marketCap":107234857021},{"date":"2024-01-12","current":31.940624,"twenty":21.240471,"median":24.991736,"eighty":29.267472,"marketCap":110824383774},{"date":"2024-01-19","current":32.155998,"twenty":21.237951,"median":24.981238,"eighty":29.255159,"marketCap":111571665008},{"date":"2024-01-26","current":31.931712,"twenty":21.240471,"median":24.991736,"eighty":29.267472,"marketCap":110793461792},{"date":"2024-02-02","current":32.222095,"twenty":21.240471,"median":24.991736,"eighty":29.267472,"marketCap":111801003042},{"date":"2024-02-09","current":30.118093,"twenty":21.240471,"median":25.033332,"eighty":29.428429,"marketCap":109015447823},{"date":"2024-02-16","current":30.421604,"twenty":21.240471,"median":25.071943,"eighty":29.609809,"marketCap":110114038882},{"date":"2024-02-23","current":30.456572,"twenty":21.240471,"median":25.132424,"eighty":29.749473,"marketCap":110240609712},{"date":"2024-03-01","current":30.025536,"twenty":21.242991,"median":25.175086,"eighty":29.834752,"marketCap":108680430503},{"date":"2024-03-08","current":29.297627,"twenty":21.242991,"median":25.208807,"eighty":29.857847,"marketCap":106045690780},{"date":"2024-03-15","current":29.171313,"twenty":21.242991,"median":25.315335,"eighty":29.857847,"marketCap":105588485946},{"date":"2024-03-22","current":29.666577,"twenty":21.242991,"median":25.403905,"eighty":29.857847,"marketCap":107381142189},{"date":"2024-03-28","current":29.781472,"twenty":21.242991,"median":25.4468,"eighty":29.862827,"marketCap":107797017773},{"date":"2024-04-05","current":28.848536,"twenty":21.240471,"median":25.567509,"eighty":29.941002,"marketCap":104420159165},{"date":"2024-04-12","current":28.578623,"twenty":21.240471,"median":25.622887,"eighty":29.941002,"marketCap":103443182848},{"date":"2024-04-19","current":28.096636,"twenty":21.28871,"median":25.675148,"eighty":29.941002,"marketCap":101698582283},{"date":"2024-04-26","current":28.397967,"twenty":21.334494,"median":25.743589,"eighty":29.939879,"marketCap":102789280711},{"date":"2024-05-03","current":28.573624,"twenty":21.408172,"median":25.808563,"eighty":29.939879,"marketCap":103425090694},{"date":"2024-05-10","current":26.899982,"twenty":21.547643,"median":25.846754,"eighty":29.939879,"marketCap":108121788619},{"date":"2024-05-17","current":28.289955,"twenty":21.652018,"median":25.895519,"eighty":29.939879,"marketCap":113708644447},{"date":"2024-05-24","current":28.942247,"twenty":21.707258,"median":25.941366,"eighty":29.939879,"marketCap":116330466859},{"date":"2024-05-31","current":28.444682,"twenty":21.77775,"median":25.976132,"eighty":29.939879,"marketCap":114330553110},{"date":"2024-06-07","current":31.171981,"twenty":21.83098,"median":25.99833,"eighty":29.979928,"marketCap":125292660990},{"date":"2024-06-14","current":30.754668,"twenty":21.89965,"median":26.020573,"eighty":30.030833,"marketCap":123615313974},{"date":"2024-06-21","current":30.263523,"twenty":21.946201,"median":26.056456,"eighty":30.088561,"marketCap":121641205564},{"date":"2024-06-28","current":30.336072,"twenty":22.010565,"median":26.07614,"eighty":30.118093,"marketCap":121932805891},{"date":"2024-07-05","current":30.192901,"twenty":22.07024,"median":26.095267,"eighty":30.153138,"marketCap":121357346838},{"date":"2024-07-12","current":31.595714,"twenty":22.139101,"median":26.117311,"eighty":30.217831,"marketCap":126995813344},{"date":"2024-07-15","current":31.378069,"twenty":22.16788,"median":26.128155,"eighty":30.255177,"marketCap":126121012362},{"date":"2024-08-02","current":-266.41813,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":130518242076},{"date":"2024-08-09","current":-245.489493,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":120265302509},{"date":"2024-08-16","current":-248.671647,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":121824239816},{"date":"2024-08-23","current":-252.828467,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":123860666197},{"date":"2024-08-30","current":-259.919824,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":127334721850},{"date":"2024-09-06","current":-246.864563,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":120938949259},{"date":"2024-09-13","current":-252.175178,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":123540619465},{"date":"2024-09-20","current":-251.780042,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":123347042813},{"date":"2024-09-27","current":-244.009054,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":119540035319},{"date":"2024-10-04","current":-238.951325,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":117062254170},{"date":"2024-10-11","current":-250.858061,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":122895363958},{"date":"2024-10-18","current":-262.754259,"twenty":22.230551,"median":26.219117,"eighty":30.262359,"marketCap":128723311702},{"date":"2024-10-25","current":-248.624231,"twenty":22.223649,"median":26.219117,"eighty":30.262359,"marketCap":121801010617},{"date":"2024-10-31","current":-250.294335,"twenty":22.211013,"median":26.219117,"eighty":30.262359,"marketCap":122619194601},{"date":"2024-11-08","current":-269.686519,"twenty":22.1449,"median":26.219117,"eighty":30.262941,"marketCap":129395591760},{"date":"2024-11-15","current":-259.762141,"twenty":22.06657,"median":26.219117,"eighty":30.262941,"marketCap":124633875188},{"date":"2024-11-22","current":-241.732944,"twenty":21.995244,"median":26.219117,"eighty":30.262941,"marketCap":115983466337},{"date":"2024-11-29","current":-251.265499,"twenty":21.929191,"median":26.17335,"eighty":30.262941,"marketCap":120557186527},{"date":"2024-12-06","current":-246.858839,"twenty":21.858672,"median":26.110746,"eighty":30.262941,"marketCap":118442871056},{"date":"2024-12-13","current":-249.11316,"twenty":21.79563,"median":26.089171,"eighty":30.262941,"marketCap":119524494074},{"date":"2024-12-20","current":-212.893742,"twenty":21.676372,"median":26.067711,"eighty":30.262941,"marketCap":102146417585},{"date":"2024-12-27","current":-220.413512,"twenty":21.568518,"median":26.035002,"eighty":30.262941,"marketCap":105754402938},{"date":"2025-01-03","current":-217.788838,"twenty":21.357971,"median":26.005972,"eighty":30.262941,"marketCap":104495084710},{"date":"2025-01-10","current":-221.197157,"twenty":21.103138,"median":25.989839,"eighty":30.263523,"marketCap":106130395701},{"date":"2025-01-17","current":-223.80036,"twenty":21.013419,"median":25.946801,"eighty":30.263523,"marketCap":107379412758},{"date":"2025-01-24","current":-236.021998,"twenty":20.944587,"median":25.928232,"eighty":30.263523,"marketCap":113243354691},{"date":"2025-01-31","current":-235.30813,"twenty":20.828961,"median":25.865987,"eighty":30.260612,"marketCap":112900840736},{"date":"2025-02-07","current":-258.25926,"twenty":20.79771,"median":25.831124,"eighty":30.192901,"marketCap":123912793176},{"date":"2025-02-14","current":-221.780914,"twenty":20.71762,"median":25.743589,"eighty":30.127053,"marketCap":118785857602},{"date":"2025-02-21","current":-230.291034,"twenty":20.630572,"median":25.67743,"eighty":30.092746,"marketCap":123343877776},{"date":"2025-02-28","current":-227.495879,"twenty":20.600663,"median":25.627235,"eighty":30.0184,"marketCap":121846792840},{"date":"2025-03-07","current":-232.875234,"twenty":20.544848,"median":25.567509,"eighty":29.953043,"marketCap":124727975170},{"date":"2025-03-14","current":-241.12166,"twenty":20.484828,"median":25.46014,"eighty":29.850334,"marketCap":129144760917},{"date":"2025-03-21","current":-244.602419,"twenty":20.445541,"median":25.388927,"eighty":29.783182,"marketCap":131009055366},{"date":"2025-03-28","current":-240.944266,"twenty":20.40278,"median":25.311106,"eighty":29.69111,"marketCap":129049748665},{"date":"2025-04-04","current":-232.055386,"twenty":20.367829,"median":25.20567,"eighty":29.625827,"marketCap":124288864494},{"date":"2025-04-11","current":-227.970528,"twenty":20.321693,"median":25.166496,"eighty":29.581337,"marketCap":122101014810},{"date":"2025-04-17","current":-232.956739,"twenty":20.276841,"median":25.093526,"eighty":29.515286,"marketCap":124771629448},{"date":"2025-04-25","current":-236.37902,"twenty":20.148332,"median":25.061636,"eighty":29.3916,"marketCap":126604603244},{"date":"2025-05-02","current":-239.446135,"twenty":20.085599,"median":25.012559,"eighty":29.298441,"marketCap":128247349837},{"date":"2025-05-09","current":-111.558369,"twenty":20.016391,"median":24.926268,"eighty":29.236258,"marketCap":110320071535},{"date":"2025-05-16","current":-112.799638,"twenty":19.960997,"median":24.877395,"eighty":29.171884,"marketCap":111547562089},{"date":"2025-05-23","current":-112.70875,"twenty":19.836167,"median":24.81003,"eighty":28.961492,"marketCap":111457683073},{"date":"2025-05-30","current":-116.100166,"twenty":19.708883,"median":24.760233,"eighty":28.88211,"marketCap":114811454335},{"date":"2025-06-06","current":-115.251014,"twenty":19.528561,"median":24.639854,"eighty":28.749145,"marketCap":113971727534},{"date":"2025-06-13","current":-119.468211,"twenty":18.953856,"median":24.576014,"eighty":28.687376,"marketCap":118142113851},{"date":"2025-06-20","current":-116.440346,"twenty":18.775971,"median":24.526022,"eighty":28.630745,"marketCap":115147858650},{"date":"2025-06-27","current":-115.141948,"twenty":18.622079,"median":24.480956,"eighty":28.576729,"marketCap":113863872715},{"date":"2025-07-03","current":-119.353952,"twenty":18.544102,"median":24.452817,"eighty":28.558653,"marketCap":118029123088},{"date":"2025-07-11","current":-124.524173,"twenty":18.385523,"median":24.383444,"eighty":28.404274,"marketCap":123141955082},{"date":"2025-07-18","current":-120.301783,"twenty":17.877735,"median":24.33314,"eighty":28.369544,"marketCap":118966432821},{"date":"2025-07-25","current":-122.638899,"twenty":17.584946,"median":24.311657,"eighty":28.3242,"marketCap":121277607504},{"date":"2025-08-01","current":-118.639833,"twenty":-111.807662,"median":24.259115,"eighty":28.28656,"marketCap":117322930824},{"date":"2025-08-08","current":26.475704,"twenty":-112.392461,"median":24.245881,"eighty":28.199436,"marketCap":96308020235},{"date":"2025-08-15","current":27.509696,"twenty":-112.392461,"median":24.245881,"eighty":28.143046,"marketCap":100069271085},{"date":"2025-08-22","current":28.014358,"twenty":-112.392461,"median":24.245881,"eighty":28.093483,"marketCap":101905028146},{"date":"2025-08-29","current":27.633042,"twenty":-112.392461,"median":24.245881,"eighty":28.035651,"marketCap":100517954724},{"date":"2025-09-05","current":27.977002,"twenty":-112.49789,"median":24.244237,"eighty":28.008674,"marketCap":101769141101},{"date":"2025-09-12","current":28.008014,"twenty":-112.392461,"median":24.245881,"eighty":27.978568,"marketCap":101881952987},{"date":"2025-09-19","current":27.284854,"twenty":-112.392461,"median":24.245881,"eighty":27.93006,"marketCap":99251384908},{"date":"2025-09-26","current":26.915521,"twenty":-112.392461,"median":24.245881,"eighty":27.853092,"marketCap":97907897897},{"date":"2025-10-03","current":28.817165,"twenty":-112.392461,"median":24.245881,"eighty":27.820175,"marketCap":104825317661},{"date":"2025-10-10","current":29.24077,"twenty":-112.392461,"median":24.245881,"eighty":27.820175,"marketCap":106366225473},{"date":"2025-10-17","current":28.800248,"twenty":-112.392461,"median":24.245881,"eighty":27.853092,"marketCap":104763783905},{"date":"2025-10-24","current":29.788427,"twenty":-112.392461,"median":24.245881,"eighty":27.911452,"marketCap":108358380832},{"date":"2025-10-31","current":29.595302,"twenty":-112.392461,"median":24.298326,"eighty":27.975071,"marketCap":107655870448},{"date":"2025-11-07","current":28.736759,"twenty":-112.392461,"median":24.318305,"eighty":28.010448,"marketCap":105610463403},{"date":"2025-11-14","current":29.99807,"twenty":-112.392461,"median":24.348681,"eighty":28.04434,"marketCap":110245906446},{"date":"2025-11-21","current":29.155815,"twenty":-112.392461,"median":24.391648,"eighty":28.102437,"marketCap":107150536707},{"date":"2025-11-28","current":29.935246,"twenty":-112.392461,"median":24.452817,"eighty":28.143046,"marketCap":110015022309},{"date":"2025-12-05","current":31.574881,"twenty":-112.392461,"median":24.48497,"eighty":28.199436,"marketCap":116040844546},{"date":"2025-12-12","current":30.785785,"twenty":-112.392461,"median":24.527661,"eighty":28.27493,"marketCap":113140838307},{"date":"2025-12-19","current":30.885889,"twenty":-112.392461,"median":24.598962,"eighty":28.318076,"marketCap":113508730612},{"date":"2025-12-26","current":31.963561,"twenty":-112.392461,"median":24.640246,"eighty":28.364533,"marketCap":117469281564},{"date":"2026-01-02","current":31.298732,"twenty":-112.392461,"median":24.726511,"eighty":28.379265,"marketCap":115025969222},{"date":"2026-01-09","current":32.42542,"twenty":-112.392461,"median":24.812775,"eighty":28.418633,"marketCap":119166660544},{"date":"2026-01-16","current":30.301834,"twenty":-112.392461,"median":24.881002,"eighty":28.516667,"marketCap":111362269302},{"date":"2026-01-23","current":32.264563,"twenty":-112.392461,"median":24.925889,"eighty":28.574361,"marketCap":118575495667},{"date":"2026-01-30","current":32.839643,"twenty":-112.392461,"median":25.002233,"eighty":28.620173,"marketCap":120688973530},{"date":"2026-02-06","current":31.674985,"twenty":-112.392461,"median":25.059097,"eighty":28.663565,"marketCap":116408736851},{"date":"2026-02-13","current":29.845272,"twenty":-112.392461,"median":25.075059,"eighty":28.713712,"marketCap":117984330791},{"date":"2026-02-20","current":30.155475,"twenty":-112.392461,"median":25.154696,"eighty":28.745553,"marketCap":119210624341},{"date":"2026-02-27","current":30.853343,"twenty":-112.392461,"median":25.202533,"eighty":28.829713,"marketCap":121969435644},{"date":"2026-03-06","current":29.612475,"twenty":-112.392461,"median":25.306876,"eighty":28.89442,"marketCap":117064035435},{"date":"2026-03-13","current":30.724822,"twenty":-112.392461,"median":25.373948,"eighty":29.042677,"marketCap":121461367264},{"date":"2026-03-20","current":29.434474,"twenty":-112.392461,"median":25.4468,"eighty":29.084793,"marketCap":116360360729},{"date":"2026-03-27","current":29.157511,"twenty":-112.392461,"median":25.565534,"eighty":29.128891,"marketCap":115265473370},{"date":"2026-04-02","current":28.741104,"twenty":-112.392461,"median":25.604812,"eighty":29.128891,"marketCap":113619331819},{"date":"2026-04-10","current":28.747051,"twenty":-112.392461,"median":25.656016,"eighty":29.128891,"marketCap":113642842403},{"date":"2026-04-17","current":28.030916,"twenty":-112.392461,"median":25.738001,"eighty":29.128891,"marketCap":110811818552},{"date":"2026-04-24","current":27.995528,"twenty":-112.392461,"median":25.822007,"eighty":29.128891,"marketCap":110671920698},{"date":"2026-05-01","current":27.498802,"twenty":-112.392461,"median":25.848109,"eighty":29.128891,"marketCap":108708263544},{"date":"2026-05-08","current":24.863956,"twenty":-112.392461,"median":25.865987,"eighty":29.128891,"marketCap":107867302225},{"date":"2026-05-15","current":26.350529,"twenty":-112.392461,"median":25.918885,"eighty":29.128891,"marketCap":114316497870},{"date":"2026-05-22","current":25.363576,"twenty":-112.392461,"median":25.918885,"eighty":29.128891,"marketCap":110034800486},{"date":"2026-05-29","current":26.20778,"twenty":-112.49789,"median":25.924143,"eighty":29.137865,"marketCap":113697212653},{"date":"2026-06-05","current":25.843304,"twenty":-112.392461,"median":25.928232,"eighty":29.128891,"marketCap":112116004905}],"updateTime":1780891883451},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641161731","title":"大冢製藥稱,腎病藥物在晚期臨床試驗中可維持腎功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161731","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641161731?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 02:37","pubTimestamp":1780598273,"startTime":"0","endTime":"0","summary":"大冢制药称,肾病药物在晚期临床试验中可维持肾功能Siddhi Mahatole/Sriparna Roy. 路透6月4日 - 大冢制药 4578.T 周四表示,其一款处于后期临床试验阶段的药物,在患有某种影响肾脏的自身免疫性疾病的患者中,成功维持了长达12个月的肾功能。该病会导致肾脏发炎,最终可能导致肾功能衰竭。该结果表明了治疗的益处,并提供了初步证据,证明该药物可能有助于减缓IgA肾病患者的肾功能衰退。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nL4T42C1MT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU1430594728.SGD","VERA","LU2362540622.SGD","IE00B19Z9P08.USD","LU0058720904.USD","LU0079474960.USD","BK4139","BK4539","VRTX","IE00B19Z9Z06.USD","LU0109394709.USD","LU2237438978.USD","IE00B4R5TH58.HKD","SG9999013999.USD","LU0061475181.USD","IE00B19Z3581.USD","LU0234570918.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4567","LU1778281490.HKD","LU0256863811.USD","IE00B894F039.SGD","LU2456880835.USD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU0320765992.SGD","BK4588","IE0002141913.USD","IE00BZ9MQY76.HKD","LU1035775433.USD","BK4532","LU1093756325.SGD","LU1674673691.USD","SG9999001176.USD","LU2362541513.USD","LU2417539215.USD","LU1585245621.USD","LU2462157665.USD","LU0417517546.SGD","LU0289739699.SGD","LU2236285917.USD","LU1069344957.HKD","BK4533","LU0432979614.USD","IE00BJJMRZ35.SGD","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141219496","title":"異動解讀|福泰製藥盤中上漲3.07%,FDA受理Povetacicept生物製品許可申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1141219496","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141219496?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 22:13","pubTimestamp":1780582383,"startTime":"0","endTime":"0","summary":"6月4日,福泰制药盘中上涨3.07%,报443.90美元/股,成交额9418.96万美元。消息面上,公司近日宣布美国FDA已正式受理其候选药物Povetacicept治疗IgA肾病的生物制品许可申请,寻求加速批准路径。加速批准通道是FDA为应对严重疾病且存在未满足医疗需求而设立的机制,Povetacicept若最终获批,有望为IgA肾病患者提供新的治疗选择。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640925582","title":"福泰製藥(VRTX)股票6月2日收盤下跌3.03%:真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2640925582","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640925582?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 04:15","pubTimestamp":1780431304,"startTime":"0","endTime":"0","summary":"• 内部人士和机构的抛售令 Vertex Pharmaceuticals 股价承压。\n• FDA 已受理 povetacicept 的生物制品许可申请(BLA),目标日期定为 2026 年 11 月 30 日。\n• 尽管近期股价下跌,但分析师大体维持“买入”评级。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/261942237-market-movers-vrtx-20260602","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","VRTX","LU2362540622.SGD","LU2237438978.USD","LU2456880835.USD","IE0009355771.USD","SG9999001176.USD","BK4588","LU1674673691.USD","IE00B2B36J28.USD","IE00BZ9MQY76.HKD","LU2417539215.USD","LU1778281490.HKD","LU0889565916.HKD","BK4139","BK4585","LU2462157665.USD","LU2362541513.USD","SG9999013999.USD","SGXZ57979304.SGD","LU2362541273.HKD","IE0002141913.USD","BK4533","LU1093756325.SGD","IE00B19Z3581.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU2236285917.USD","IE00B4R5TH58.HKD","LU1674673428.USD","LU0256863811.USD","LU0061475181.USD","IE00B19Z9Z06.USD","LU1093756168.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","BK4532","LU1035775433.USD","LU1430594728.SGD","LU0289739699.SGD","IE00B894F039.SGD","LU0234570918.USD","LU0058720904.USD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU0079474960.USD","LU1069344957.HKD","LU0823416689.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116756628","title":"異動解讀|福泰製藥盤中下跌3.06%,FDA受理Povetacicept生物製品許可申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1116756628","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116756628?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 01:47","pubTimestamp":1780422456,"startTime":"0","endTime":"0","summary":"6月3日,福泰制药盘中下跌3.06%,报425.0美元/股,成交额1.78亿美元。消息面上,公司近日宣布美国FDA已正式受理其候选药物Povetacicept治疗IgA肾病的生物制品许可申请,寻求加速批准路径。加速批准通道是FDA为应对严重疾病且存在未满足医疗需求而设立的机制,Povetacicept若最终获批,有望为IgA肾病患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147010136","title":"異動解讀|福泰製藥盤中下跌3.09%,FDA受理Povetacicept生物製品許可申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1147010136","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147010136?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 23:29","pubTimestamp":1780327790,"startTime":"0","endTime":"0","summary":"6月1日,福泰制药盘中下跌3.09%,报433.71美元/股,成交额1.22亿美元。消息面上,公司宣布美国FDA已正式受理其候选药物Povetacicept治疗IgA肾病的生物制品许可申请,寻求加速批准路径。加速批准通道是FDA为应对严重疾病且存在未满足医疗需求而设立的机制,Povetacicept若最终获批,有望为IgA肾病患者提供新的治疗选择。福泰制药是一家全球性生物技术公司,已开发出针对囊性纤维化、镰状细胞病等病症的获批疗法,并持续推进IgA肾病、1型糖尿病等领域的临床项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153443248","title":"福泰製藥宣佈美國FDA受理其生物製品許可申請 尋求Povetacicept在IgA腎病中的加速批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1153443248","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153443248?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 20:01","pubTimestamp":1780315299,"startTime":"0","endTime":"0","summary":"福泰制药(Vertex Pharmaceuticals)近日宣布,美国食品药品监督管理局(FDA)已正式受理其提交的生物制品许可申请(BLA),该申请旨在为候选药物Povetacicept在治疗免疫球蛋白A肾病(IgA肾病)领域寻求加速批准路径。\n此举标志着该药物在监管审批进程中迈出了关键一步。加速批准通道是美国FDA为应对严重疾病且存在未满足医疗需求的情况而设立的一种机制,旨在加快重要疗法的可及性。Povetacicept若最终获批,有望为IgA肾病患者提供一种新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU2456880835.USD","IE00B19Z3B42.SGD","LU2417539215.USD","LU2362540622.SGD","BK4567","IE0009355771.USD","IE00BZ9MQY76.HKD","LU0234570918.USD","LU1430594728.SGD","LU1778281490.HKD","LU2236285917.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU2362541513.USD","SG9999013999.USD","IE0002141913.USD","IE00B2B36J28.USD","BK4532","BK4588","LU0889565916.HKD","BK4139","LU0432979614.USD","LU2237438978.USD","LU1069344957.HKD","SGXZ57979304.SGD","BK4533","IE00B19Z9P08.USD","LU0256863811.USD","IE00BJT1NW94.SGD","LU1035775433.USD","LU1674673428.USD","IE00B19Z9Z06.USD","LU2362541273.HKD","LU0109394709.USD","LU0417517546.SGD","LU1674673691.USD","LU0320765992.SGD","LU0061475181.USD","LU1585245621.USD","LU1093756325.SGD","LU2324357040.USD","SG9999001176.SGD","LU2462157665.USD","VRTX","LU0079474960.USD","IE0002270589.USD","SG9999001176.USD","BK4585","LU0823416689.USD","IE00BJJMRZ35.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122799679","title":"福泰製藥宣佈舒澤曲吉新藥上市申請獲加拿大衞生部受理,用於治療成人中重度急性疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1122799679","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122799679?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 01:00","pubTimestamp":1779382813,"startTime":"0","endTime":"0","summary":"福泰制药(Vertex Pharmaceuticals)宣布,其新药舒泽曲吉(Suzetrigine)用于治疗成人中重度急性疼痛的上市申请,已获加拿大卫生部受理并进入审评阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","LU0289739699.SGD","VRTX","SG9999013999.USD","LU0417517546.SGD","LU2417539215.USD","LU0823416689.USD","LU0234570918.USD","IE0002270589.USD","LU0058720904.USD","LU1778281490.HKD","LU0432979614.USD","IE00B894F039.SGD","SG9999001176.SGD","LU2236285917.USD","SG9999001176.USD","LU1674673691.USD","IE00B19Z3B42.SGD","LU2462157665.USD","IE00B19Z9Z06.USD","IE0009355771.USD","LU1093756325.SGD","BK4585","LU1035775433.USD","LU2324357040.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4139","LU2237438978.USD","LU1430594728.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B19Z3581.USD","BK4533","LU1674673428.USD","BK4588","LU1585245621.USD","LU2362540622.SGD","SGXZ57979304.SGD","LU1069344957.HKD","LU1093756168.USD","LU0109394709.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0079474960.USD","IE00BJT1NW94.SGD","LU0256863811.USD","LU0320765992.SGD","IE00B19Z9P08.USD","LU2362541513.USD","LU0061475181.USD","BK4532","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636816228","title":"美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636816228","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636816228?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 15:08","pubTimestamp":1779260900,"startTime":"0","endTime":"0","summary":"美国研究综述-CAVA集团、Eagle Materials、Vertiv控股路透5月20日 - 周三,华尔街的证券分析师们修订了多家在美国上市公司的评级和目标股价,其中包括CAVA集团、Eagle Materials和Vertiv控股。股票条目按字母顺序排列。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4T41X0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0878866978.SGD","DRUG","LU0130103400.USD","LU0417517546.SGD","VRTX","BRO","EXP","MRNX","HALO","IE00BMPRXR70.SGD","VRT","THC","LU0098860793.USD","BK4548","LU2290526834.HKD","BK4139","CHRW","IE00B1XK9C88.USD","BK4585","LU2462157665.USD","LU1989772840.SGD","LU0868494708.USD","LU2543165471.USD","IE00B7SZLL34.SGD","IE00BN0W2V16.EUR","IONS","CAVA","IE00BKPKM429.USD","LU0882574055.USD","BMRN","VRTL","MRNY","LU2108987350.USD","INSM","LU1035775433.USD","LU0943347566.SGD","LU2249611893.SGD","ALNY","HD","UTHR","INCY","IE0002270589.USD","BK4534","RLAY","LU2720916845.USD","UHS","LU2065731478.USD","MIRM","JAZZ","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636162238","title":"美國研究綜述-CAVA集團、Eagle Materials、Vertiv控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636162238","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636162238?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 15:08","pubTimestamp":1779260900,"startTime":"0","endTime":"0","summary":"美国研究综述-CAVA集团、Eagle Materials、Vertiv控股路透5月20日 - 周三,华尔街的证券分析师们修订了多家在美国上市公司的评级和目标股价,其中包括CAVA集团、Eagle Materials和Vertiv控股。股票条目按字母顺序排列。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4S41X0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","LU0868494617.USD","IE00B19Z9P08.USD","LU1035775433.USD","MRNY","BK4568","EXP","LU1551013342.USD","THC","LU0823414551.USD","LU2362541513.USD","LU2125909916.SGD","BK4083","INSM","IE0002270589.USD","IE0009355771.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","SG9999001440.SGD","UTHR","IONS","VRT","MIRM","VRTX","UHS","BMRN","LU0238689110.USD","CHRW","LU2456880835.USD","INCY","MRNA","BRO","MRNX","DRUG","LU1303367103.USD","LU0079474960.USD","ALNY","VRTL","HD","BK4501","LU0061475181.USD","LU0878866978.SGD","BK4534","LU1929549753.HKD","RLAY","JAZZ","CAVA","IE00B1XK9C88.USD","LU0942090050.USD","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130830224","title":"福泰製藥與德國達成協議 確保12歲及以上符合條件的患者獲得Casgevy治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1130830224","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130830224?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 19:02","pubTimestamp":1778065351,"startTime":"0","endTime":"0","summary":"福泰制药近日宣布与德国相关方面达成重要协议,将确保12岁及以上符合条件的患者能够获得其基因编辑疗法Casgevy。这一突破性安排标志着该创新疗法在德国市场的可及性取得重大进展。\n根据协议条款,符合临床标准的青少年和成人患者将有机会接受这一变革性治疗。Casgevy作为基于CRISPR技术的基因编辑疗法,有望为特定遗传疾病患者提供新的治疗选择。\n此次合作展现了福泰制药持续致力于扩大创新疗法的可及性,同时也反映了德国医疗体系对前沿医疗技术的接纳与支持。该协议的落实将为符合条件的患者群体带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU1430594728.SGD","SG9999001176.USD","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2236285917.USD","BK4139","LU1674673428.USD","LU2362540622.SGD","LU1035775433.USD","LU2362541273.HKD","LU1674673691.USD","LU0234570918.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU2362541513.USD","IE00BZ9MQY76.HKD","LU1093756325.SGD","BK4532","SG9999013999.USD","LU0061475181.USD","SGXZ57979304.SGD","SG9999001176.SGD","IE00B894F039.SGD","BK4585","BK4567","IE0009355771.USD","LU2417539215.USD","BK4588","LU2456880835.USD","LU1778281490.HKD","LU1585245621.USD","IE00B19Z3581.USD","LU2462157665.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","IE00B19Z9Z06.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0256863811.USD","BK4533","IE0002270589.USD","LU0823416689.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0079474960.USD","LU2324357040.USD","LU2237438978.USD","VRTX","LU1093756168.USD","IE0002141913.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186373938","title":"福泰製藥在德國達成Casgevy®基因療法報銷協議 覆蓋鐮狀細胞病與輸血依賴型β地中海貧血治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1186373938","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186373938?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 19:01","pubTimestamp":1778065307,"startTime":"0","endTime":"0","summary":"福泰制药宣布与德国医保系统达成重要突破——其革命性基因疗法Casgevy已获得镰状细胞病和输血依赖型β地中海贫血的报销协议。这一里程碑式协议将显著提升德国罕见血液疾病患者对尖端CRISPR基因编辑疗法的可及性。作为全球首款获批的CRISPR基因编辑疗法,Casgevy通过一次性治疗有望从根本上解决遗传性血红蛋白疾病的病因。此次报销协议的落地,不仅为符合治疗条件的德国患者扫除了费用障碍,也为福泰制药在欧洲市场的商业化拓展奠定了关键基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE0002270589.USD","LU1430594728.SGD","LU2362540622.SGD","LU1674673428.USD","IE00B19Z9P08.USD","LU0058720904.USD","LU0079474960.USD","BK4139","LU0823416689.USD","VRTX","IE00B19Z9Z06.USD","LU0109394709.USD","LU2237438978.USD","LU2362541273.HKD","IE00B4R5TH58.HKD","SG9999013999.USD","LU1674673691.USD","LU0061475181.USD","IE00B19Z3581.USD","LU0234570918.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4567","LU1778281490.HKD","LU0256863811.USD","IE00B894F039.SGD","LU2456880835.USD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU0320765992.SGD","BK4588","IE0002141913.USD","IE00BZ9MQY76.HKD","IE0009355771.USD","BK4532","LU1035775433.USD","LU1093756168.USD","LU1093756325.SGD","SG9999001176.USD","LU2362541513.USD","LU2417539215.USD","LU1585245621.USD","LU2462157665.USD","SG9999001176.SGD","LU0417517546.SGD","LU0289739699.SGD","LU2236285917.USD","LU1069344957.HKD","BK4533","LU0432979614.USD","IE00BJJMRZ35.SGD","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633992020","title":"美國研究綜述-應用材料公司、Axsome Therapeutics、安森美半導體","url":"https://stock-news.laohu8.com/highlight/detail?id=2633992020","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633992020?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 15:08","pubTimestamp":1777964887,"startTime":"0","endTime":"0","summary":"美国研究综述-应用材料公司、Axsome Therapeutics、安森美半导体路透5月5日 - 周二,华尔街证券分析师修订了多家美国上市公司的评级和目标股价,其中包括应用材料公司、Axsome Therapeutics和安森美半导体。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL4T41I0FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSCC","H","AMAT","GPI","VVX","NCLH","NOW","MZTI","CHD","DT","DDOG","ON","DUOL","THC","CRCL","ARE","SAH","ESPR","TVTX","CRWV","FLGT","AEIS","HUBB","TSN","INSP","WGS","PINS","CLYM","SEER","SGMT","CBRE","ICHR","AXSM","VRTX","ACMR","RBLX","CVX","PLTR","RBA","BR","CNO","GBTG","EVER","KNSL","LRCX","SLG","TWST","APD","RYAN","COIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633963154","title":"Vertex公司盈利超出預期,新型囊性纖維化藥物銷量激增","url":"https://stock-news.laohu8.com/highlight/detail?id=2633963154","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633963154?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 04:02","pubTimestamp":1777924963,"startTime":"0","endTime":"0","summary":"路透5月4日 - Vertex Pharmaceuticals VRTX.O 周一公布的季度调整后利润超出华尔街预期,这主要得益于其 新款囊性纤维化治疗药物销售额激增近八倍 。该公司的新款囊性 纤维化药物——每日一次的三联疗法Alyftrek——在第一季度创下4.244亿美元的销售额,而 去年同期仅为5390万美元 ,增幅达687%。该公司重申了其年度 营收预期,预计 将在129.5亿美元至131 亿美元之间。自Journavx于去年3月上市以来,处方量已超过100万张。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL4T41H1GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0320765992.SGD","LU1778281490.HKD","LU2362541273.HKD","SG9999013999.USD","BK4567","LU0432979614.USD","SGXZ57979304.SGD","LU0256863811.USD","IE0002141913.USD","IE00B894F039.SGD","LU2417539215.USD","LU0417517546.SGD","IE00B19Z9Z06.USD","LU2362540622.SGD","LU1035775433.USD","BK4588","IE00BZ9MQY76.HKD","LU1430594728.SGD","IE00BFTCPJ56.SGD","VRTX","LU0823416689.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","SG9999001176.USD","LU2362541513.USD","IE0009355771.USD","LU1093756168.USD","IE0002270589.USD","LU0058720904.USD","LU1585245621.USD","BK4139","LU1069344957.HKD","LU2462157665.USD","LU0061475181.USD","LU2456880835.USD","LU1093756325.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU2237438978.USD","BK4585","LU0889565916.HKD","LU1674673428.USD","IE00B19Z9P08.USD","BK4532","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149148329","title":"財報前瞻|福泰製藥本季度營收預計小幅增長,機構觀點偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1149148329","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149148329?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 08:04","pubTimestamp":1777248282,"startTime":"0","endTime":"0","summary":"福泰制药将于2026年05月04日发布新季度财报,市场聚焦核心管线商业化节奏与盈利能力韧性。市场一致预期显示,本季度福泰制药营收预计为30.34亿美元,同比增6.36%;调整后每股收益预计为4.33美元,同比增0.88%;息税前利润预计为12.43亿美元,同比降0.84%。主营业务“产品”收入31.90亿美元,同比增长9.55%,延续稳步增长态势。近期覆盖机构观点以偏多为主。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|福泰制药本季度营收预计小幅增长,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625958488","title":"BUZZ-Vertex簽署全球藥物輸送技術協議,Halozyme股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2625958488","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625958488?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:35","pubTimestamp":1775565317,"startTime":"0","endTime":"0","summary":"BUZZ-Vertex签署全球药物输送技术协议,Halozyme股价上涨4月7日 - ** 药物输送公司Halozyme Therapeutics HALO.O股价盘前上涨3%至64.93美元** 该公司称,它与Vertex Pharmaceuticals VRTX.O公司就其Hypercon药物输送技术签署了一项全球独家许可协议,该技术可使药物以较小的体积注射。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4S40Q0V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","IE0009355771.USD","IE00B19Z9P08.USD","LU2462157665.USD","LU1093756168.USD","IE00B19Z3B42.SGD","LU2362540622.SGD","LU0079474960.USD","LU1585245621.USD","LU0289739699.SGD","LU2456880835.USD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU0109394709.USD","LU0320765992.SGD","SG9999013999.USD","LU2324357040.USD","SGXZ57979304.SGD","BK4139","LU0053671581.USD","LU2236285917.USD","LU2362541273.HKD","BK4585","BK4567","IE00B894F039.SGD","LU0256863811.USD","BK4532","LU0823416689.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE0002270589.USD","IE00B2B36J28.USD","LU0058720904.USD","LU2237438978.USD","HALO","LU1035775433.USD","LU0432979614.USD","IE00B4R5TH58.HKD","LU0234570918.USD","VRTX","SG9999001176.USD","BK4533","BK4588","LU0889565916.HKD","LU1430594728.SGD","LU2362541513.USD","LU1674673691.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624508187","title":"美國FDA批准福泰製藥Alyftrek和Trikafta標籤擴展","url":"https://stock-news.laohu8.com/highlight/detail?id=2624508187","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624508187?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 18:43","pubTimestamp":1775126585,"startTime":"0","endTime":"0","summary":"金吾财讯 | 福泰制药(VRTX)周三表示,美国食品药品监督管理局已批准Alyftrek和Trikafta的标签扩展,用于治疗囊性纤维化患者。更新后的标签现在包括具有任何导致CFTR蛋白生成的CFTR基因变异的患者,这是基于临床和体外数据得出的。此外,富国集团分析师Mohit Bansal维持福泰制药“买入”评级,目标价从515美元上调至550美元。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298695","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0320765992.SGD","LU1778281490.HKD","LU2362541273.HKD","BK4567","LU0432979614.USD","LABU","SG9999001176.SGD","LU0256863811.USD","IE0002141913.USD","IE00B894F039.SGD","LU0079474960.USD","LU2417539215.USD","LU0417517546.SGD","IE00B19Z9Z06.USD","LU2362540622.SGD","LU1035775433.USD","BK4588","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU1430594728.SGD","IE00BFTCPJ56.SGD","VRTX","IE00B19Z3581.USD","LU0109394709.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","SG9999001176.USD","LU2362541513.USD","IE0009355771.USD","LU0234570918.USD","LU1093756168.USD","IE0002270589.USD","LU0058720904.USD","LU1585245621.USD","BK4139","LU1069344957.HKD","LU2462157665.USD","LU0061475181.USD","LU2456880835.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1674673691.USD","BK4585","LU2236285917.USD","LU0889565916.HKD","LU1674673428.USD","IE00B19Z9P08.USD","BK4532","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144704237","title":"福泰製藥宣佈美國FDA批准Alyftrek®與Trikafta®標籤擴展,覆蓋全美約95%囊性纖維化患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1144704237","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144704237?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043034,"startTime":"0","endTime":"0","summary":"福泰制药近日宣布,其药物Alyftrek®与Trikafta®已获得美国食品药品监督管理局(FDA)的标签扩展批准。这一重要进展将显著扩大两款药物的适用人群范围,预计可使美国约95%的囊性纤维化(CF)患者获得治疗机会。此次标签扩展标志着福泰制药在CF治疗领域取得又一突破,为更广泛的患者群体提供了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","BK4139","LU0889565916.HKD","LU0289739699.SGD","LU0432979614.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU0256863811.USD","BK4567","IE00B19Z3581.USD","BK4588","IE00B894F039.SGD","LU0823416689.USD","SG9999013999.USD","IE00B19Z3B42.SGD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU2417539215.USD","LU1093756325.SGD","LU0109394709.USD","BK4533","LU1035775433.USD","LU2456880835.USD","SG9999001176.USD","LU1069344957.HKD","LU0079474960.USD","LU1585245621.USD","IE0009355771.USD","LU0061475181.USD","LU1430594728.SGD","LU2324357040.USD","BK4532","IE0002270589.USD","LU2237438978.USD","LU2362540622.SGD","LU0234570918.USD","BK4585","LU2362541513.USD","LU2362541273.HKD","LU2462157665.USD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1674673691.USD","LU1778281490.HKD","LU0320765992.SGD","LU1674673428.USD","IE00B19Z9P08.USD","LU2236285917.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","VRTX","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196872785","title":"福泰製藥完成向FDA提交Povetacicept治療成人IgAN的生物製劑許可申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1196872785","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196872785?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 04:21","pubTimestamp":1774988477,"startTime":"0","endTime":"0","summary":"福泰制药(Vertex Pharmaceuticals)宣布,已正式完成向美国食品药品监督管理局(FDA)提交其候选药物Povetacicept针对成人免疫球蛋白A肾病(IgAN)治疗的生物制剂许可申请(BLA)。此次提交标志着该药物在监管审批流程中迈出关键一步。\n根据公开的SEC文件披露,此次BLA提交涵盖了Povetacicept在IgAN患者中的临床数据。若获批,该药物有望为这一缺乏有效治疗手段的疾病领域提供新的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","LU0320765992.SGD","LU1069344957.HKD","LU2236285917.USD","VRTX","LU0889565916.HKD","LU0289739699.SGD","LU1430594728.SGD","LU2462157665.USD","LU0058720904.USD","BK4533","LU0432979614.USD","SG9999001176.USD","LU1585245621.USD","LU2362540622.SGD","BK4139","LU1093756325.SGD","IE00B2B36J28.USD","BK4588","BK4585","IE00B4R5TH58.HKD","BK4567","SG9999013999.USD","LU2362541273.HKD","LU0823416689.USD","BK4532","IE00BZ9MQY76.HKD","LU0079474960.USD","LU2456880835.USD","IE00BJJMRZ35.SGD","LU1674673428.USD","IE00B19Z9Z06.USD","LU2362541513.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","LU0234570918.USD","LU1778281490.HKD","LU1093756168.USD","IE00B19Z3581.USD","LU0061475181.USD","LU2237438978.USD","IE00B19Z3B42.SGD","IE0002141913.USD","LU0256863811.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","IE0002270589.USD","LU1035775433.USD","LU2417539215.USD","SGXZ57979304.SGD","LU1674673691.USD","LU0109394709.USD","IE00B894F039.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623880065","title":"BUZZ-董事會聘用多發性硬化症藥物資深專家後,Immunic 股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2623880065","media":"路透中文","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623880065?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 18:56","pubTimestamp":1774954562,"startTime":"0","endTime":"0","summary":"BUZZ-董事会聘用多发性硬化症药物资深专家后,Immunic 股价上涨3月31日 - ** 生物技术公司ImmunicIMUX.O股价盘前上涨5%至1.08美元 ** 该公司称已任命康格尔顿为董事会成员;他曾帮助梯瓦公司在美国推出多发性硬化症药物Copaxone** 康格尔顿还担任过Mineralys Therapeutics、Impel NeuroPharma和Nivalis Therapeutics的首席执行官。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL4S40J0XL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","LU2236285917.USD","IE00B19Z9Z06.USD","LU0058720904.USD","LU2237438978.USD","BK4588","LU2362541273.HKD","IE00BJJMRZ35.SGD","LU1035775433.USD","LU0432979614.USD","SG9999001176.USD","LU2362540622.SGD","BK4585","LU0234570918.USD","SG9999001176.SGD","SGXZ57979304.SGD","LU2417539215.USD","LU1585245621.USD","BK4533","IE00BFTCPJ56.SGD","LU1674673691.USD","LU0256863811.USD","BK4139","LU0079474960.USD","LU0889565916.HKD","BK4532","IE0009355771.USD","SG9999013999.USD","IMUX","BK4567","LU0289739699.SGD","LU2456880835.USD","LU2362541513.USD","LU1069344957.HKD","LU1778281490.HKD","MLYS","IE0002141913.USD","LU1093756168.USD","IE00BZ9MQY76.HKD","LU1674673428.USD","IE00B894F039.SGD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU0417517546.SGD","LU2462157665.USD","VRTX","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620725950","title":"BUZZ-Vertex 因腎病藥物數據獲得券商評級上調而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2620725950","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620725950?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 21:13","pubTimestamp":1773839626,"startTime":"0","endTime":"0","summary":"BUZZ-Vertex 因肾病药物数据获得券商评级上调而上涨3月18日 - ** 制药商Vertex Pharmaceuticals VRTX.O股价盘前上涨1.1%至463.96美元** 经纪商Maxim Group将Vertex的评级从 \"持有 \"上调至 \"买入\";将目标价从之前的无目标上调至575美元,理由是povetacicept数据良好** 该公司称,晚期中期数据显示,实验性肾病药物povetacicept达到了治疗IgA肾病的主要目标和所有次要目标,IgA肾病是一种可导致肾衰竭的肾病。** Maxim 认为 povetacicept 有可能成为重磅药物,并有助于实现 Vertex 囊性纤维化药物以外的收入多样化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4T406169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0432979614.USD","IE00BJJMRZ35.SGD","LU1035775433.USD","IE00BZ9MQY76.HKD","LU2462157665.USD","BK4533","LU0256863811.USD","LU1674673428.USD","LU1093756325.SGD","VRTX","BK4567","IE00BFTCPJ56.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU2362540622.SGD","LU0109394709.USD","IE00B19Z3581.USD","LU2362541273.HKD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1674673691.USD","IE0002270589.USD","IE00B894F039.SGD","SG9999001176.USD","LU1430594728.SGD","LU0079474960.USD","LU1093756168.USD","IE0002141913.USD","BK4588","LU0417517546.SGD","IE00B2B36J28.USD","BK4139","LU0234570918.USD","BK4532","LU1585245621.USD","LU2362541513.USD","LU2456880835.USD","LU0889565916.HKD","LU0058720904.USD","LU2236285917.USD","IE0009355771.USD","LU0061475181.USD","SG9999013999.USD","SG9999001176.SGD","LU1778281490.HKD","LU2324357040.USD","SGXZ57979304.SGD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}